Some aspects of application of the combination of formoterol and budesonide: what is changed?

per A. A. Vizel, I. Yu. Vizel
Publicat 2019-12-01

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation

per A. A. Vizel, I. Yu. Vizel
Publicat 2019-12-01

12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review

per A. A. Vizel, I. Yu. Vizel
Publicat 2018-10-01

CHRONIC OBSTRUCTIVE PULMONARY DISEASE – AB INITIO TILL PRESENT (historical literature review)

per A. A. Vizel, I. Yu. Vizel
Publicat 2019-03-01

Leflunomide as a potential second-line drug in the treatment of sarcoidosis

per A. A. Vizel, I. Yu. Vizel
Publicat 2019-09-01

Characteristics of population of patients with sarcoidiosis in the republic of Tatarstan: the results of multi-year monitoring

per I. Yu. Vizel, A. A. Vizel, G. R. Shakirova, G. S. Ganibaeva
Publicat 2018-11-01

The Use of Inhaled Glucocorticosteroids (ICS) during the COVID-19 Pandemic

per A. A. Vizel, I. Yu. Vizel, M. K. Sagdieva, F. F. Yarkaeva
Publicat 2022-02-01

Assessment of the effect of alpha-tocopherol on the course of newly diagnosed pulmonary sarcoidosis: a comparative study

per A. A. Vizel, D. A. Culver, I. Yu. Vizel, G. R. Shakirova, E. A. Bakunina
Publicat 2020-11-01